Table 2.
Outcome according to histology. All transplants were preceded by dialysis apart from one child with Mesangioproliferative histology who received pre-emptive transplantation
| n | Remission | Dialysis | Renal transplantation | Mortality rate | Persistent NS | Lost to follow-up | Follow-up (months) (range) | |
|---|---|---|---|---|---|---|---|---|
| MesGN | 13 | 3 (23 %) | 4 (31 %) | 3 (8 %) | 2 (15 %) | 2 (15 %) | 1 (8 %) | 155(51-180) |
| FSGS | 12 | 2 (17 %) | 6(50 %) | 3 (25 %) | 2 (17 %) | 2 (17 %) | 1 (8 %) | 26 (5-216) |
| Finnish | 11 | 1(9 %) | 5 (55.5 %) | 4 (44 %) | 3 (27 %) | 1 (9 %) | 2 (18 %) | 44 (14-79) |
| DMS | 8 | 0 (0 %) | 3 (37.5 %) | 2 (25 %) | 4 (50 %) | 1 (13 %) | 1 (13 %) | 55 (19-195) |
| MCD | 3 | 1 (33 %) | 1 (33.3 %) | 1 (33 %) | 1 (33 %) | 1 (33 %) | 0 (0 %) | 192(118-222) |
| Other | 2 | 1 (50 %) | 1 (50 %) | 1 (50 %) | 0 (0 %) | 0 (0 %) | 0 (0 %) | 44-48 |
| Total | 49 | 8 (16 %) | 20 (41 %) | 14 (29 %) | 12 (24 %) | 7 (14 %) | 5 (10 %) | 73 (5-222) |
MesGN mesangial proliferative glomerulopathy, FSGS focal segmental glomerulosclerosis, DMS diffuse mesangial sclerosis, MCD minimal change disease, NS nephrotic syndrome